{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T05:24:03Z","timestamp":1793337843913,"version":"4.5.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,9,9]]},"DOI":"10.7759\/cureus.28981","type":"journal-article","created":{"date-parts":[[2022,9,9]],"date-time":"2022-09-09T18:08:51Z","timestamp":1662746931000},"source":"Crossref","is-referenced-by-count":8,"title":["Glucocorticoids-Induced Neuropsychiatric Disorders in Patients With Inflammatory Bowel Disease: A Systematic Review"],"prefix":"10.7759","author":[{"given":"Safina","family":"Ali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salomi","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shreyas","family":"Yakkali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sneha","family":"Teresa Selvin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonu","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktoriya","family":"Bikeyeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Abdullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Radivojevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anas A","family":"Abu Jad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anvesh","family":"Ravanavena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chetna","family":"Ravindra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelar O","family":"Igweonu-Nwakile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pousette","family":"Hamid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(19)30333-4","article-title":"The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"5","author":"Global Burden of Disease 2017 Inflammatory Bowel Disease Collaborators","year":"2020","unstructured":"Global Burden of Disease 2017 Inflammatory Bowel Disease Collaborators. The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol. 2020, 5:17-30. 10.1016\/S2468-1253(19)30333-4","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI30587","article-title":"The fundamental basis of inflammatory bowel disease","volume":"117","author":"Strober W","year":"2007","unstructured":"Strober W, Fuss I, Mannon P. The fundamental basis of inflammatory bowel disease. J Clin Invest. 2007, 117:514-21. 10.1172\/JCI30587","journal-title":"J Clin Invest"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32448-0","article-title":"Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies","volume":"390","author":"Ng SC","year":"2017","unstructured":"Ng SC, Shi HY, Hamidi N, et al.. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 2017, 390:2769-78. 10.1016\/S0140-6736(17)32448-0","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2019-318484","article-title":"British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults","volume":"68","author":"Lamb CA","year":"2019","unstructured":"Lamb CA, Kennedy NA, Raine T, et al.. British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut. 2019, 68:s1-s106. 10.1136\/gutjnl-2019-318484","journal-title":"Gut"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.765474","article-title":"Treatment of inflammatory bowel disease: a comprehensive review","volume":"8","author":"Cai Z","year":"2021","unstructured":"Cai Z, Wang S, Li J. Treatment of inflammatory bowel disease: a comprehensive review. Front Med (Lausanne). 2021, 8:765474. 10.3389\/fmed.2021.765474","journal-title":"Front Med (Lausanne)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.691480","article-title":"Glucocorticoid therapy in inflammatory bowel disease: mechanisms and clinical practice","volume":"12","author":"Bruscoli S","year":"2021","unstructured":"Bruscoli S, Febo M, Riccardi C, Migliorati G. Glucocorticoid therapy in inflammatory bowel disease: mechanisms and clinical practice. Front Immunol. 2021, 12:691480. 10.3389\/fimmu.2021.691480","journal-title":"Front Immunol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000001261","article-title":"Safety considerations with the use of corticosteroids and biologic therapies in mild-to-moderate ulcerative colitis","volume":"23","author":"Cross RK","year":"2017","unstructured":"Cross RK. Safety considerations with the use of corticosteroids and biologic therapies in mild-to-moderate ulcerative colitis. Inflamm Bowel Dis. 2017, 23:1689-701. 10.1097\/MIB.0000000000001261","journal-title":"Inflamm Bowel Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/jcag\/gwy023","article-title":"Rate of corticosteroid-induced mood changes in patients with inflammatory bowel disease: a prospective study","volume":"1","author":"Ou G","year":"2018","unstructured":"Ou G, Bressler B, Galorport C, et al.. Rate of corticosteroid-induced mood changes in patients with inflammatory bowel disease: a prospective study. J Can Assoc Gastroenterol. 2018, 1:99-106. 10.1093\/jcag\/gwy023","journal-title":"J Can Assoc Gastroenterol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.4088\/pcc.v03n0104","article-title":"Mood and cognitive changes during systemic corticosteroid therapy","volume":"3","author":"Brown ES","year":"2001","unstructured":"Brown ES, Chandler PA. Mood and cognitive changes during systemic corticosteroid therapy. Prim Care Companion J Clin Psychiatry. 2001, 3:17-21. 10.4088\/pcc.v03n0104","journal-title":"Prim Care Companion J Clin Psychiatry"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/jcag\/gwy038","article-title":"Addressing mental health in persons with IBD","volume":"1","author":"Bernstein CN","year":"2018","unstructured":"Bernstein CN. Addressing mental health in persons with IBD. J Can Assoc Gastroenterol. 2018, 1:97-8. 10.1093\/jcag\/gwy038","journal-title":"J Can Assoc Gastroenterol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.20873","article-title":"Depression and anxiety in inflammatory bowel disease: a review of comorbidity and management","volume":"15","author":"Graff LA","year":"2009","unstructured":"Graff LA, Walker JR, Bernstein CN. Depression and anxiety in inflammatory bowel disease: a review of comorbidity and management. Inflamm Bowel Dis. 2009, 15:1105-18. 10.1002\/ibd.20873","journal-title":"Inflamm Bowel Dis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.22916","article-title":"Mood disorders in inflammatory bowel disease: relation to diagnosis, disease activity, perceived stress, and other factors","volume":"18","author":"Goodhand JR","year":"2012","unstructured":"Goodhand JR, Wahed M, Mawdsley JE, Farmer AD, Aziz Q, Rampton DS. Mood disorders in inflammatory bowel disease: relation to diagnosis, disease activity, perceived stress, and other factors. Inflamm Bowel Dis. 2012, 18:2301-9. 10.1002\/ibd.22916","journal-title":"Inflamm Bowel Dis"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021, 372:n71. 10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-200202000-00009","article-title":"Mood changes during prednisone bursts in outpatients with asthma","volume":"22","author":"Brown ES","year":"2002","unstructured":"Brown ES, Suppes T, Khan DA, Carmody TJ 3rd. Mood changes during prednisone bursts in outpatients with asthma. J Clin Psychopharmacol. 2002, 22:55-61. 10.1097\/00004714-200202000-00009","journal-title":"J Clin Psychopharmacol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1080\/08998280.2019.1629223","article-title":"Steroid-induced psychosis","volume":"32","author":"Janes M","year":"2019","unstructured":"Janes M, Kuster S, Goldson TM, Forjuoh SN. Steroid-induced psychosis. Proc (Bayl Univ Med Cent). 2019, 32:614-5. 10.1080\/08998280.2019.1629223","journal-title":"Proc (Bayl Univ Med Cent)"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2014.13091264","article-title":"Adverse consequences of glucocorticoid medication: psychological, cognitive, and behavioral effects","volume":"171","author":"Judd LL","year":"2014","unstructured":"Judd LL, Schettler PJ, Brown ES, et al.. Adverse consequences of glucocorticoid medication: psychological, cognitive, and behavioral effects. Am J Psychiatry. 2014, 171:1045-51. 10.1176\/appi.ajp.2014.13091264","journal-title":"Am J Psychiatry"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.22888","article-title":"Risk factors of anxiety and depression in inflammatory bowel disease","volume":"18","author":"Nahon S","year":"2012","unstructured":"Nahon S, Lahmek P, Durance C, Olympie A, Lesgourgues B, Colombel JF, Gendre JP. Risk factors of anxiety and depression in inflammatory bowel disease. Inflamm Bowel Dis. 2012, 18:2086-91. 10.1002\/ibd.22888","journal-title":"Inflamm Bowel Dis"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12669","article-title":"The incidence and risk factors for developing depression after being diagnosed with inflammatory bowel disease: a cohort study","volume":"39","author":"Panara AJ","year":"2014","unstructured":"Panara AJ, Yarur AJ, Rieders B, Proksell S, Deshpande AR, Abreu MT, Sussman DA. The incidence and risk factors for developing depression after being diagnosed with inflammatory bowel disease: a cohort study. Aliment Pharmacol Ther. 2014, 39:802-10. 10.1111\/apt.12669","journal-title":"Aliment Pharmacol Ther"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.psym.2012.06.006","article-title":"Rapid reversal of corticosteroid-induced mania with sodium valproate: a case series of 20 patients","volume":"53","author":"Roxanas MG","year":"2012","unstructured":"Roxanas MG, Hunt GE. Rapid reversal of corticosteroid-induced mania with sodium valproate: a case series of 20 patients. Psychosomatics. 2012, 53:575-81. 10.1016\/j.psym.2012.06.006","journal-title":"Psychosomatics"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/101419-glucocorticoids-induced-neuropsychiatric-disorders-in-patients-with-inflammatory-bowel-disease-a-systematic-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:47:01Z","timestamp":1707508021000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/101419-glucocorticoids-induced-neuropsychiatric-disorders-in-patients-with-inflammatory-bowel-disease-a-systematic-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,9]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.28981","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9,9]]}}}